Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Most pregnancies with SLE resulted in intrauterine growth restriction (IUGR).

Skin may help in getting rid of excess iron through the process of skin cell renewal.

Recognizing and treating overlap syndrome in connective tissue diseases is crucial.

A woman with severe hair loss due to systemic sclerosis regrew her hair in 4 months using a combination of treatments.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Fibromyalgia slightly more common in SLE patients but doesn't affect SLE activity assessments.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Systemic diseases can cause hair loss, which is often reversible with treatment.

Looking at skin can help find and treat serious diseases early.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.

Combining Cyclosporine A with low-dose corticosteroids effectively treats severe alopecia areata.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Finasteride microspheres help reduce hair loss for up to eight weeks with fewer side effects.

Dexpanthenol improves hair growth and satisfaction in women without side effects.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Higher BMI may increase the risk of psoriasis and some other skin diseases.

High leptin levels may promote skin cancer and inflammation, suggesting potential for leptin-targeted therapies.

CD19-CAR T cell therapy may help regenerate skin in systemic sclerosis.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Systemic steroids temporarily improve severe alopecia areata in children but often lead to relapse.

Systemic corticosteroids help manage vitiligo by slowing progression and aiding repigmentation.

Early recognition and tailored treatment are crucial for managing overlapping systemic lupus erythematosus and systemic sclerosis.

A 16-year-old girl with autoimmune hemolytic anemia and deep vein thrombosis improved with treatment, possibly indicating systemic lupus erythematosus.

Immediate post-operative folliculitis is a reaction to surgery, not an infection.

Body structure can help identify alopecia areata in Ukrainian men, but not predict its course.